Fabian Heinz, Thi Ngoc Anh Ngo, Eiden Michael, Lasch Peter, Schmitt Jürgen, Naumann Dieter
Robert Koch-Institute, P25, Nordufer 20, 13353 Berlin, Germany.
Biochim Biophys Acta. 2006 Jul;1758(7):874-82. doi: 10.1016/j.bbamem.2006.05.015. Epub 2006 May 23.
The collection of IR spectra through microscope optics and the visualization of the IR data by IR imaging represent a visualization approach, which uses infrared spectral features as a native intrinsic contrast mechanism. To illustrate the potential of this spectroscopic methodology in breast cancer research, we have acquired IR-microspectroscopic data from benign and malignant lesions in breast tissue sections by point microscopy with spot sizes of 30-40 microm. Four classes of distinct breast tissue spectra were defined and stored in the data base: fibroadenoma (a total of 1175 spectra from 14 patients), ductal carcinoma in situ (a total of 1349 spectra from 8 patients), connective tissue (a total of 464 spectra), and adipose tissue (a total of 146 spectra). Artifical neural network analysis, a supervised pattern recognition method, was used to develop an automated classifier to separate the four classes. After training the artifical neural network classifier, infrared spectra of independent external validation data sets ("unknown spectra") were analyzed. In this way, all spectra (a total of 386) taken from micro areas inside the epithelium of fibroadenomas from 4 patients were correctly classified. Out of the 421 spectra taken from micro areas of the in situ component of invasive ductal carcinomas of 3 patients, 93% were correctly identified. Based on these results, the potential of the IR-microspectroscopic approach for diagnosing breast tissue lesions is discussed.
通过显微镜光学系统收集红外光谱,并通过红外成像对红外数据进行可视化,这代表了一种可视化方法,该方法将红外光谱特征用作天然的固有对比机制。为了说明这种光谱方法在乳腺癌研究中的潜力,我们通过点显微镜对乳腺组织切片中的良性和恶性病变获取了红外显微光谱数据,光斑尺寸为30 - 40微米。定义了四类不同的乳腺组织光谱并存储在数据库中:纤维腺瘤(来自14名患者的总共1175个光谱)、导管原位癌(来自8名患者的总共1349个光谱)、结缔组织(总共464个光谱)和脂肪组织(总共146个光谱)。人工神经网络分析是一种监督模式识别方法,用于开发一个自动分类器来区分这四类。在训练人工神经网络分类器后,对独立外部验证数据集(“未知光谱”)的红外光谱进行了分析。通过这种方式,来自4名患者纤维腺瘤上皮内微区的所有光谱(总共386个)都被正确分类。在来自3名患者浸润性导管癌原位成分微区的421个光谱中,93%被正确识别。基于这些结果,讨论了红外显微光谱方法在诊断乳腺组织病变方面的潜力。